Thomas Kallemose

Medicine & Life Sciences

1. Urokinase Plasminogen Activator Receptors 100%
2. Knee Replacement Arthroplasties 42%
3. Randomized Controlled Trials 42%
4. Hip 31%
5. Knee 30%
6. Denmark 29%
7. Hospital Emergency Service 28%
8. Coronavirus 26%
9. Chronic Obstructive Pulmonary Disease 25%
10. Mortality 25%
11. Arthroplasty 25%
12. Achilles Tendon 24%
13. Cohort Studies 24%
14. Biomarkers 22%
15. Radiostereometric Analysis 19%
16. Inflammatory Bowel Diseases 19%
17. Rehabilitation 17%
18. Rupture 17%
19. SARS Virus 17%
20. Amputation 15%
21. Telerehabilitation 14%
22. Exercise 14%
23. Leukocyte L1 Antigen Complex 13%
24. Hallux Rigidus 13%
25. Registries 12%
26. Inflammation 12%
27. Retrospective Studies 12%
28. Population 12%
29. Meta-Analysis 12%
30. Observational Studies 12%
31. Joints 11%
32. Outpatients 11%
33. Equivalence Trials 11%
34. Incidence 11%
35. Osteoarthritis 11%
36. Multimorbidity 10%
37. Placebos 10%
38. Tranexamic Acid 10%
39. Hereditary Nonpolyposis Colorectal Neoplasms 10%
40. Prospective Studies 10%
41. Patient Readmission 10%
42. Resistance Training 9%
43. Femoral Fractures 9%
44. Colorectal Neoplasms 9%
45. Knee Osteoarthritis 9%
46. Control Groups 9%
47. Articular Range of Motion 9%
48. Therapeutics 9%
49. Hip Fractures 9%
50. Fibrosis 9%